Eating Disorders Relating to GLP-1 RA Treatment
The National Eating Disorders Collaboration (NEDC) has released a new article exploring the relationship between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and eating disorders.
The article addresses the increased use of GLP-1 RAs in primary care, the eating disorder-related risks they carry to those undergoing treatment that utilises GLP-1 RAs, and recommendations for medical practitioners to help mitigate these risks.
You can read the full article from the NEDC here.